A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

Inhalers that combine relieving breathlessness with preventing it seem to be the most effective option for reducing asthma ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

Australia has overhauled the way asthma is treated, with doctors advised to stop prescribing blue “reliever” puffers alone ...

New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and ...

The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which combines the inhaled corticosteroid (ICS) budesonide and the fast-acting bronchodilator formoterol – reduced ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.In the first ...

The National Asthma Council’s advice for treating the condition has been updated, advising doctors against solely prescribing blue puffers to patients.